CollPlant Secures New Capital Raise
Categories: Capital Markets
CollPlant, a regenerative and aesthetic medicine company headquartered in Israel, has completed a registered direct offering alongside a concurrent private placement to advance its biomedical development pipeline and strategic growth.
A cross-office team from international law firm Greenberg Traurig advised CollPlant on the transaction. The matter was led by Shareholder Mark Selinger, with additional support from shareholders Gary Emmanuel and Eyal Peled, and associate Brandon Sloane.
